By Associated Press Undefined BRUSSELS (AP) — The European Union has fined two pharmaceutical companies for colluding to keep a cheap alternative to a sleep disorder medicine off the market for their profit and at the expense of patients. EU antitrust commissioner, Margrethe Vestager, said that Teva pharmaceuticals and Cephalon, a company it later acquired, must pay 60.5 million euros ($72 million) for agreeing between themselves to delay for years the launch of Teva's cheaper version of Cephalon's blockbuster Modafinil. In return for the delay, Teva got beneficial side deals and some payments. Vestager said that 'Teva's and Cephalon's pay-for-delay […]

The post EU fines drug makers for keeping cheap medicine off market appeared first on Black News Channel.